Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
No est aprobado como medicamento ni suplemento
This milestone represents a meaningful shift in Novo Nordisk recently received FDA approval to bring its oral semaglutide formulation, Rybelsus, under the Ozempic brand aligning oral and injectable semaglutide for type 2 diabetes under a single, highly recognized name On February 24, 2026, Novo Nordisk announced it will significantly reduce the wholesale acquisition cost (WAC) of several of its GLP1 therapies, effective January 1, 2027
By lowering glucagon levels after meals, GLP-1 prevents unwanted spikes in your blood glucose, further supporting healthy glucose management
Most injection appointments are completed in approximately 1520 minutes, depending on your consultation and selected services
US$ 21.89
US$ 20.03
US$ 29.11
US$ 28.32
US$ 21.77
US$ 29.97
